METHODS FOR TREATMENT OF DISORDERS OF CIRCADIAN SLEEP RHYTHM Russian patent published in 2021 - IPC A61K31/506 A61P43/00 

Abstract RU 2763493 C2

FIELD: pharmaceutics.

SUBSTANCE: group of inventions relates to the field of pharmaceutics, namely to methods for the treatment of an irregular sleep-wake rhythm, associated increased sleepiness and/or daytime drowsiness, a disorder of a circadian sleep rhythm due to Alzheimer’s disease, selected from sleep interruption, sleep-wake fragmentation and irregular sleep-wake rhythm, to methods for the improvement of nighttime sleep continuity, behavioral and cognitive problems in a subject with an irregular sleep-wake rhythm, with dementia due to Alzheimer’s disease, with mild cognitive impairment due to Alzheimer’s disease, to methods for the stabilization and improvement of one or several circadian rhythms in a subject. Methods include the injection of the effective amount of at least one compound selected from ((1R,2S)-2-(((2,4-dimethylpyrimidine-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridine-2-yl)cyclopropancarboxamide, its pharmaceutically acceptable salts and solvates, once a day every day before sleep or once a day every other day before sleep.

EFFECT: group of inventions provides for the creation of safe and effective therapy that is easy for the injection for the treatment of sleep-wake fragmentation in patients with an irregular sleep-wake rhythm.

42 cl, 2 dwg, 2 tbl, 5 ex

Similar patents RU2763493C2

Title Year Author Number
USE OF AN INVERSE AGONIST H3R FOR TREATING SLEEP DISORDER IN SHIFT WORK 2018
  • Kucher, Klaus
  • Sovago, Judit
  • Johns, Donald
RU2768894C2
NEW COMBINATIONS OF H3 RECEPTOR ANTAGONISTS AND NOREPINEPHRINE REUPTAKE INHIBITORS AND THEIR THERAPEUTIC USE 2019
  • Ligneau, Xavier
  • Landais, Laurent
  • Perrin, David
  • Lecomte, Jeanne Marie
  • Schwartz, Jean Charles
RU2809163C2
METHOD OF TREATING EXCESSIVE DAYTIME SLEEPINESS (VERSIONS) 2006
  • Akhnaou Abdallakh
  • Drinkenburg Vil'Gel'Mus Kh. I. M.
  • Palumbo Dzhozef
  • Sporn Dzhonatan
RU2417077C2
HETEROCYCLIC COMPOUND AS INHIBITOR OF CASEIN KINASE 1δ AND/OR ACTIVIN RECEPTOR-LIKE KINASE 5 2021
  • Tanaka, Keigo
RU2810065C1
MELATONIN AGONIST THERAPY 2007
  • Birzhneks Gunter
  • Padke Dipak
  • Polimeropoulos Majkl Kh.
RU2488392C2
TREATMENT OF CIRCADIAN RHYTHM DISORDERS 2013
  • Dressman Marlin Mishell
  • Fini Dzhon Dzhozef
  • Lajkemil Luis Uillyam
  • Polimeropoulos Mikhael Kh.
RU2748386C2
METABOLITES (1R-TRANS)-N-[[2-(2,3-DIGIDRO-4-BENZOFURANYL)CYCLOPROPYL]-METHYL]PROPANAMIDE 2013
  • Dressman Marlin Mishell
  • Fadke Dipak
RU2632889C2
WAY TO IMPROVE SLEEP 2020
  • Polymeropoulos Mihael
  • Smieszek Sandra
RU2804441C2
METHODS FOR THE USE OF CYCLIC AMIDE DERIVATIVES FOR TREATMENT OF SIGMA-RECEPTOR-MEDIATED DISORDERS 2011
  • Luthringer, Remy, Henri
  • Pellegrini, Lorenzo
  • Karabelas, Argeris, N.
RU2746871C2
SYSTEM AND METHOD FOR PHOTOTHERAPY 2009
  • Uehlls Kevin
  • Kolbo Majkl Ehdvard
RU2545904C2

RU 2 763 493 C2

Authors

Beuckmann, Carsten, T.

Moline, Margaret

Satlin, Andrew

Dates

2021-12-29Published

2017-05-11Filed